Literature DB >> 445949

Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives.

R K Roberts, P V Desmond, G R Wilkinson, S Schenker.   

Abstract

There is considerable interspecies and interdrug variability in the effect of sex differences and oral contraceptive (OC) steroids on hepatic drug elimination. Their influence on the disposition of chlordiazepoxide has been studied in 11 healthy young men (29 +/- 5 yr), 11 healthy young women (28 +/- 5 yr), and 7 healthy women receiving OC steroids (27 +/- 2 yr) for more than 6 months. The elimination half-life (t1/2(beta)) was longer (from 14.8 +/- 5.9 hr to 8.9 +/- 2.5 hr) and protein binding less (95.5 +/- 1.4% and 97.0 +/- 1.2%) in women than in men. Weight-normalized plasma clearances of total drug did not differ, but the clearance of unbound drug was significantly less in women (8.7 +/- 5.0 ml/min/kg) than in men (15.6 +/- 5.3 ml/min/kg). Women on OC steroids had a lower plasma binding (from 93.6 +/- 1.5% to 95.5 +/- 1.4%) and a higher volume of distribution (from 0.62 +-/ 0.23 l/kg to 0.40 +/- 0.14 l/kg) than women not on OC steroids. The elimination t1/2 was longer (from 24.3 +/- 12 hr to 14.8 +/- 5.9 hr) and the clearance of unbound drug lower (from 5.7 +/- 3.0 ml/min/kg to 8.7 +/- 5.0 ml/min/kg) in women on OC steroids than in those not using them, but these differences were not statistically significant.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Correlation Studies; Ethinyl Estradiol; Family Planning; Hematological Effects; Hemic System; Hepatic Effects; Men; Mestranol; Metabolic Effects; Norethynodrel; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Research Methodology; Serum Protein Effects; Statistical Studies; Steroid Metabolic Effects; Studies; Women

Mesh:

Substances:

Year:  1979        PMID: 445949     DOI: 10.1002/cpt1979256826

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

Review 1.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

2.  Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers.

Authors:  V K Nayak; N A Kshirsagar; N K Desai; R S Satoskar
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 3.  Plasma protein binding of drugs in pregnancy.

Authors:  E Perucca; A Crema
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

4.  Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Authors:  P J Meffin; L M Wing; B C Sallustio; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 5.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

6.  The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.

Authors:  K Groen; M A Horan; N A Roberts; R S Gulati; B Miljkovic; E J Jansen; V Paramsothy; D D Breimer; C F van Bezooijen
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

7.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

8.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

Review 9.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 10.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.